NASDAQ:MBII - Marrone Bio Innovations Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.78 +0.07 (+4.09 %)
(As of 05/27/2018 04:00 PM ET)
Previous Close$1.78
Today's Range$1.71 - $1.80
52-Week Range$0.85 - $3.39
Volume300,813 shs
Average Volume449,587 shs
Market Capitalization$196.63 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.52

About Marrone Bio Innovations (NASDAQ:MBII)

Marrone Bio Innovations logoMarrone Bio Innovations, Inc. provides bio-based pest management and plant health products primarily for agricultural and water markets in the United States and internationally. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation. The company's products include Regalia, a plant extract-based fungicidal biopesticide for plant disease control and plant health; and Grandevo, a bioinsecticide for insect and mite control to the growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens, and ornamental plants. It also provides Zequanox, a biomolluscicide that controls invasive mussels, which cause infrastructure and ecological damage primarily to power and industrial companies; and Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes. In addition, the company offers Haven, an anti-transpirant plant health product that reduces plant stress and dehydration; and Majestene, a bionematicide to control soil-dwelling nematodes by preventing and reducing root galls, as well as reducing adult reproduction and egg hatch. Marrone Bio Innovations, Inc. provides its products directly, as well as through distributors. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was founded in 2006 and is headquartered in Davis, California.

Receive MBII News and Ratings via Email

Sign-up to receive the latest news and ratings for MBII and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNASDAQ:MBII
CUSIPN/A
Phone530-750-2800

Debt

Debt-to-Equity Ratio1.40
Current Ratio2.63
Quick Ratio1.76

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$18.17 million
Price / Sales10.82
Cash FlowN/A
Price / CashN/A
Book Value$0.12 per share
Price / Book14.83

Profitability

EPS (Most Recent Fiscal Year)($1.07)
Net Income$-30,920,000.00
Net Margins-144.82%
Return on EquityN/A
Return on Assets-62.44%

Miscellaneous

Employees103
Outstanding Shares110,470,000

Marrone Bio Innovations (NASDAQ:MBII) Frequently Asked Questions

What is Marrone Bio Innovations' stock symbol?

Marrone Bio Innovations trades on the NASDAQ under the ticker symbol "MBII."

How were Marrone Bio Innovations' earnings last quarter?

Marrone Bio Innovations (NASDAQ:MBII) posted its quarterly earnings results on Thursday, March, 29th. The basic materials company reported ($0.24) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.26) by $0.02. The basic materials company earned $3.32 million during the quarter. View Marrone Bio Innovations' Earnings History.

What price target have analysts set for MBII?

3 equities research analysts have issued 1-year target prices for Marrone Bio Innovations' shares. Their predictions range from $1.00 to $4.00. On average, they expect Marrone Bio Innovations' share price to reach $2.1833 in the next year. View Analyst Ratings for Marrone Bio Innovations.

Who are some of Marrone Bio Innovations' key competitors?

Who are Marrone Bio Innovations' key executives?

Marrone Bio Innovations' management team includes the folowing people:
  • Dr. Pamela G. Marrone, Founder, CEO & Director (Age 61)
  • Mr. James B. Boyd, Pres & CFO (Age 65)
  • Ms. Linda V. Moore, Chief Compliance Officer, Gen. Counsel, Exec. VP & Sec. (Age 71)
  • Dr. Amit Vasavada Ph.D., Sr. VP of R&D and CTO (Age 63)
  • Mr. Brian R. Ahrens, VP of Sales & Bus. Devel. (Age 47)

Has Marrone Bio Innovations been receiving favorable news coverage?

Media headlines about MBII stock have trended somewhat positive on Sunday, according to Accern Sentiment. The research group identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Marrone Bio Innovations earned a daily sentiment score of 0.20 on Accern's scale. They also assigned news coverage about the basic materials company an impact score of 48.03 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Marrone Bio Innovations?

Shares of MBII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Marrone Bio Innovations' stock price today?

One share of MBII stock can currently be purchased for approximately $1.78.

How big of a company is Marrone Bio Innovations?

Marrone Bio Innovations has a market capitalization of $196.63 million and generates $18.17 million in revenue each year. The basic materials company earns $-30,920,000.00 in net income (profit) each year or ($1.07) on an earnings per share basis. Marrone Bio Innovations employs 103 workers across the globe.

How can I contact Marrone Bio Innovations?

Marrone Bio Innovations' mailing address is 1540 Drew Avenue, Davis CA, 95618. The basic materials company can be reached via phone at 530-750-2800 or via email at [email protected]


MarketBeat Community Rating for Marrone Bio Innovations (MBII)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  105 (Vote Outperform)
Underperform Votes:  154 (Vote Underperform)
Total Votes:  259
MarketBeat's community ratings are surveys of what our community members think about Marrone Bio Innovations and other stocks. Vote "Outperform" if you believe MBII will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBII will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Marrone Bio Innovations (NASDAQ:MBII) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Marrone Bio Innovations in the last 12 months. Their average twelve-month price target is $2.1833, suggesting that the stock has a possible upside of 22.66%. The high price target for MBII is $4.00 and the low price target for MBII is $1.00. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.332.332.33
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.1833$2.1833$2.50$2.50
Price Target Upside: 22.66% upside18.02% upside138.10% upside127.27% upside

Marrone Bio Innovations (NASDAQ:MBII) Consensus Price Target History

Price Target History for Marrone Bio Innovations (NASDAQ:MBII)

Marrone Bio Innovations (NASDAQ:MBII) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/15/2018HC WainwrightReiterated RatingBuy$4.00LowView Rating Details
3/21/2018Jefferies GroupReiterated RatingHold$1.55LowView Rating Details
7/22/2017Piper Jaffray CompaniesSet Price TargetHold$1.00HighView Rating Details
(Data available from 5/27/2016 forward)

Earnings

Marrone Bio Innovations (NASDAQ:MBII) Earnings History and Estimates Chart

Earnings by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Marrone Bio Innovations (NASDAQ:MBII) Earnings Estimates

2018 EPS Consensus Estimate: ($0.14)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.04)($0.04)($0.04)
Q2 20181($0.03)($0.03)($0.03)
Q3 20181($0.04)($0.04)($0.04)
Q4 20181($0.03)($0.03)($0.03)

Marrone Bio Innovations (NASDAQ MBII) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/29/2018Q4 2017($0.26)($0.24)$3.32 millionViewListenView Earnings Details
11/13/2017Q3 2017($0.24)($0.27)$5.32 million$4.22 millionViewN/AView Earnings Details
8/14/2017Q2 2017($0.21)($0.25)$6.62 million$6.48 millionViewN/AView Earnings Details
5/11/2017Q1 2017($0.31)($0.31)$4.15 millionViewN/AView Earnings Details
3/29/2017Q4 2016($0.26)($0.3170)$2.69 millionViewN/AView Earnings Details
11/14/2016Q316($0.22)($0.29)$4.61 million$3.63 millionViewN/AView Earnings Details
8/9/2016Q216($0.28)($0.28)$4.61 million$5.00 millionViewN/AView Earnings Details
5/12/2016Q116($0.27)($0.38)$3.05 million$2.70 millionViewListenView Earnings Details
3/30/2016Q215($0.40)($0.45)$1.10 million$1.90 millionViewListenView Earnings Details
11/17/2015Q3 2015($0.40)$2.48 millionViewN/AView Earnings Details
8/7/2014Q2 2014($0.49)($0.50)$7.59 million$3.63 millionViewN/AView Earnings Details
5/13/2014Q114($0.37)($0.52)$4.63 million$2.80 millionViewN/AView Earnings Details
3/6/2014Q4 2013($0.40)($0.52)$5.80 million$5.97 millionViewN/AView Earnings Details
11/7/2013Q3 2013($0.47)($0.53)$2.02 million$1.35 millionViewN/AView Earnings Details
9/12/2013Q2 2013($0.33)($2.36)$4.33 million$4.50 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Marrone Bio Innovations (NASDAQ:MBII) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Marrone Bio Innovations (NASDAQ MBII) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.80%
Institutional Ownership Percentage: 35.39%
Insider Trading History for Marrone Bio Innovations (NASDAQ:MBII)
Institutional Ownership by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Marrone Bio Innovations (NASDAQ MBII) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/12/2018Van Herk Investments B.V.Major ShareholderSell5,000$1.23$6,150.00View SEC Filing  
2/5/2018Ardsley Advisory PartnersInsiderBuy6,666,667$0.75$5,000,000.25View SEC Filing  
2/1/2018Waddell & Reed Financial IncInsiderSell800$2.11$1,688.00View SEC Filing  
9/30/2017Waddell & Reed Financial IncInsiderBuy11,300$2.77$31,301.00View SEC Filing  
6/6/2017Waddell & Reed Financial IncInsiderBuy2,500,000$9.50$23,750,000.00View SEC Filing  
5/16/2017Waddell & Reed Financial IncInsiderBuy51,788$9.25$479,039.00View SEC Filing  
5/14/2017Waddell & Reed Financial IncInsiderBuy16,700$9.46$157,982.00View SEC Filing  
4/25/2017Ardsley Advisory PartnersMajor ShareholderBuy50,000$1.72$86,000.00View SEC Filing  
6/15/2016Richard E RomingerDirectorBuy10,000$0.94$9,400.003,836View SEC Filing  
6/13/2016James BoydCFOBuy10,000$0.79$7,900.005,000View SEC Filing  
6/9/2016George H KerckhoveDirectorBuy2,500$0.72$1,800.003,000View SEC Filing  
6/9/2016Pamela G MarroneCEOBuy5,000$0.72$3,600.00795,309View SEC Filing  
6/9/2016Timothy B JohnsonVPBuy10,000$0.72$7,200.0010,000View SEC Filing  
8/14/2014George H KerckhoveDirectorBuy400$5.90$2,360.00View SEC Filing  
8/12/2014Pamela G MarroneCEOBuy1,000$5.29$5,290.00View SEC Filing  
2/12/2014Ventures Pte. Ltd. Syngentamajor shareholderSell332,027$14.72$4,887,437.441,889,877View SEC Filing  
1/29/2014Donald GlidewellCFOSell75,495$17.00$1,283,415.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Marrone Bio Innovations (NASDAQ MBII) News Headlines

Source:
DateHeadline
Marrone Bio Innovations, Inc. to Present at 8th Annual LD Micro Invitational Investor Conference in Los AngelesMarrone Bio Innovations, Inc. to Present at 8th Annual LD Micro Invitational Investor Conference in Los Angeles
finance.yahoo.com - May 25 at 8:57 AM
Marrone Bio Innovations Expands Sales Team and Establishes New Sales TerritoryMarrone Bio Innovations Expands Sales Team and Establishes New Sales Territory
finance.yahoo.com - May 24 at 9:00 AM
Zacks Investment Research Upgrades Marrone Bio Innovations (MBII) to "Hold"Zacks Investment Research Upgrades Marrone Bio Innovations (MBII) to "Hold"
www.americanbankingnews.com - May 18 at 5:15 PM
Edited Transcript of MBII earnings conference call or presentation 10-May-18 8:30pm GMTEdited Transcript of MBII earnings conference call or presentation 10-May-18 8:30pm GMT
finance.yahoo.com - May 17 at 5:20 PM
Marrone Bio Innovations (MBII) Buy Rating Reaffirmed at HC WainwrightMarrone Bio Innovations' (MBII) Buy Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - May 15 at 1:19 PM
Marrone Bio Innovations (MBII) Rating Lowered to Sell at Zacks Investment ResearchMarrone Bio Innovations (MBII) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - May 12 at 10:38 AM
Marrone Bio Innovations (MBII) CEO Pam Marrone on Q1 2018 Results - Earnings Call TranscriptMarrone Bio Innovations' (MBII) CEO Pam Marrone on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 9:33 AM
Evogene (EVGN) and Marrone Bio Innovations (MBII) Report Phase Advancement in Insect Control Collaboration on Positive Results in Model PlantsEvogene (EVGN) and Marrone Bio Innovations (MBII) Report Phase Advancement in Insect Control Collaboration on Positive Results in Model Plants
www.streetinsider.com - May 11 at 9:44 AM
Marrone Bio Innovations, Inc. Reports First Quarter 2018 Financial ResultsMarrone Bio Innovations, Inc. Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 10 at 5:02 PM
Comparing Marrone Bio Innovations (MBII) & SenesTech (SNES)Comparing Marrone Bio Innovations (MBII) & SenesTech (SNES)
www.americanbankingnews.com - May 9 at 9:15 PM
Marrone Bio Innovations Appoints Kevin Hammill as New Chief Commercial OfficerMarrone Bio Innovations Appoints Kevin Hammill as New Chief Commercial Officer
finance.yahoo.com - May 7 at 8:57 AM
Marrone Bio Innovations (MBII) Receives Average Recommendation of "Hold" from AnalystsMarrone Bio Innovations (MBII) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 7 at 3:46 AM
-$0.04 EPS Expected for Marrone Bio Innovations (MBII) This Quarter-$0.04 EPS Expected for Marrone Bio Innovations (MBII) This Quarter
www.americanbankingnews.com - May 5 at 9:24 PM
Marrone Bio Innovations (MBII) Upgraded by Zacks Investment Research to "Hold"Marrone Bio Innovations (MBII) Upgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - May 5 at 1:07 AM
Marrone Bio Innovations to Report First Quarter 2018 Financial Results on Thursday, May 10th at 1:30 p.m. Pacific timeMarrone Bio Innovations to Report First Quarter 2018 Financial Results on Thursday, May 10th at 1:30 p.m. Pacific time
finance.yahoo.com - May 3 at 8:59 AM
Marrone Bio Innovations (MBII) Stock Rating Upgraded by ValuEngineMarrone Bio Innovations (MBII) Stock Rating Upgraded by ValuEngine
www.americanbankingnews.com - May 3 at 12:10 AM
Marrone Bio Innovations to Present at 3rd Annual RHK Capital Disruptive Growth & Healthcare Conference in New York on May 8thMarrone Bio Innovations to Present at 3rd Annual RHK Capital Disruptive Growth & Healthcare Conference in New York on May 8th
finance.yahoo.com - May 1 at 9:06 AM
Grandevo® CG and Venerate® CG Approved for Use on Cannabis by the Colorado, Washington and Nevada Departments of AgricultureGrandevo® CG and Venerate® CG Approved for Use on Cannabis by the Colorado, Washington and Nevada Departments of Agriculture
finance.yahoo.com - April 30 at 9:12 AM
Marrone Bio Innovations Announces Exercise of Over-Allotment Option in Public Offering of Common StockMarrone Bio Innovations Announces Exercise of Over-Allotment Option in Public Offering of Common Stock
feeds.benzinga.com - April 26 at 6:10 PM
Marrone Bio inks pact with Israeli agricultural distributorMarrone Bio inks pact with Israeli agricultural distributor
finance.yahoo.com - April 26 at 4:45 PM
Marrone Bio Innovations and Lidorr Chemicals Ltd. Sign Distribution Agreement in IsraelMarrone Bio Innovations and Lidorr Chemicals Ltd. Sign Distribution Agreement in Israel
feeds.benzinga.com - April 25 at 4:27 PM
Marrone Bio raises $12 million in secondary stock offeringMarrone Bio raises $12 million in secondary stock offering
finance.yahoo.com - April 19 at 4:57 PM
CF Industries (CF) & Marrone Bio Innovations (MBII) Financial ComparisonCF Industries (CF) & Marrone Bio Innovations (MBII) Financial Comparison
www.americanbankingnews.com - April 19 at 8:42 AM
-$0.04 Earnings Per Share Expected for Marrone Bio Innovations (MBII) This Quarter-$0.04 Earnings Per Share Expected for Marrone Bio Innovations (MBII) This Quarter
www.americanbankingnews.com - April 18 at 9:13 PM
BRIEF-Marrone Bio Innovations Announces Pricing Of Common Stock OfferingBRIEF-Marrone Bio Innovations Announces Pricing Of Common Stock Offering
www.reuters.com - April 18 at 5:03 PM
Marrone Bio Innovations, Inc. Announces Pricing of Its Common Stock OfferingMarrone Bio Innovations, Inc. Announces Pricing of Its Common Stock Offering
finance.yahoo.com - April 18 at 9:05 AM
Marrone Bio Innovations -4.9% on share offeringMarrone Bio Innovations -4.9% on share offering
seekingalpha.com - April 17 at 6:27 PM
BRIEF-Marrone Bio Innovations Announces Proposed Public Offering Of Common StockBRIEF-Marrone Bio Innovations Announces Proposed Public Offering Of Common Stock
www.reuters.com - April 17 at 5:13 PM
MicroCap Review Magazine Spring 2018 Issue Now AvailableMicroCap Review Magazine Spring 2018 Issue Now Available
finance.yahoo.com - April 17 at 9:24 AM
Regalia® CG Biofungicide Cleared for Use on Cannabis by the Colorado, Oregon, Washington and Nevada Departments of AgricultureRegalia® CG Biofungicide Cleared for Use on Cannabis by the Colorado, Oregon, Washington and Nevada Departments of Agriculture
finance.yahoo.com - April 16 at 8:58 AM
Head to Head Survey: Calyxt (CLXT) and Marrone Bio Innovations (MBII)Head to Head Survey: Calyxt (CLXT) and Marrone Bio Innovations (MBII)
www.americanbankingnews.com - April 15 at 1:39 AM
Marrone Bio Innovations (MBII) Lowered to Buy at BidaskClubMarrone Bio Innovations (MBII) Lowered to Buy at BidaskClub
www.americanbankingnews.com - April 12 at 10:22 AM
Marrone Bio Innovations (MBII) Given Average Recommendation of "Hold" by BrokeragesMarrone Bio Innovations (MBII) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 12 at 3:52 AM
Marrone Bio Innovations (MBII) Cut to Sell at Zacks Investment ResearchMarrone Bio Innovations (MBII) Cut to Sell at Zacks Investment Research
www.americanbankingnews.com - April 11 at 7:56 AM
Marrone Bio Innovations (MBII) Downgraded to Sell at ValuEngineMarrone Bio Innovations (MBII) Downgraded to Sell at ValuEngine
www.americanbankingnews.com - April 10 at 9:44 AM
BRIEF-Marrone Bio Innovations Files Prospectus Relates To Offering Of Up To 119 Mln Shares Of Cos Common Stock By Selling StockholdersBRIEF-Marrone Bio Innovations Files Prospectus Relates To Offering Of Up To 119 Mln Shares Of Co's Common Stock By Selling Stockholders
www.reuters.com - April 9 at 9:14 AM
Marrone Bio Innovations (MBII) Lifted to Sell at ValuEngineMarrone Bio Innovations (MBII) Lifted to Sell at ValuEngine
www.americanbankingnews.com - April 7 at 10:37 AM
Why Marrone Bio shares rose 22 percent FridayWhy Marrone Bio shares rose 22 percent Friday
www.bizjournals.com - April 7 at 9:29 AM
Is Marrone Bio Innovations (MBII) Stock a Solid Choice Right Now?Is Marrone Bio Innovations (MBII) Stock a Solid Choice Right Now?
finance.yahoo.com - April 6 at 9:23 AM
Research Analysts Set Expectations for Marrone Bio Innovations Incs FY2018 Earnings (MBII)Research Analysts Set Expectations for Marrone Bio Innovations Inc's FY2018 Earnings (MBII)
www.americanbankingnews.com - April 5 at 7:58 AM
Marrone Bio Innovations Inc Forecasted to Post Q1 2018 Earnings of ($0.04) Per Share (MBII)Marrone Bio Innovations Inc Forecasted to Post Q1 2018 Earnings of ($0.04) Per Share (MBII)
www.americanbankingnews.com - April 4 at 7:33 AM
BRIEF-Marrone Bio Innovations Inc Files For Non-Timely 10-K With U.S. SECBRIEF-Marrone Bio Innovations Inc Files For Non-Timely 10-K With U.S. SEC
www.reuters.com - April 3 at 4:49 PM
More on Marrone Bio FY 2017 resultsMore on Marrone Bio FY 2017 results
seekingalpha.com - April 2 at 4:50 PM
Marrone Bio Innovations to Present at The MicroCap Conference in New York on April 9thMarrone Bio Innovations to Present at The MicroCap Conference in New York on April 9th
globenewswire.com - April 2 at 9:32 AM
BRIEF-Marrone Bio Innovations Says Q4 Revenue Rose 23.3 Pct To $3.3 MlnBRIEF-Marrone Bio Innovations Says Q4 Revenue Rose 23.3 Pct To $3.3 Mln
www.reuters.com - March 30 at 9:08 AM
Edited Transcript of MBII earnings conference call or presentation 29-Mar-18 9:00pm GMTEdited Transcript of MBII earnings conference call or presentation 29-Mar-18 9:00pm GMT
finance.yahoo.com - March 30 at 9:08 AM
Marrone Bio Innovations (MBII) Issues  Earnings Results, Beats Expectations By $0.02 EPSMarrone Bio Innovations (MBII) Issues Earnings Results, Beats Expectations By $0.02 EPS
www.americanbankingnews.com - March 30 at 8:48 AM
Marrone Bio Innovations, Inc. Reports Record Full Year 2017 Financial ResultsMarrone Bio Innovations, Inc. Reports Record Full Year 2017 Financial Results
finance.yahoo.com - March 29 at 4:48 PM
Marrone Bio Innovations to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 29th at 2:00 p.m. Pacific timeMarrone Bio Innovations to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 29th at 2:00 p.m. Pacific time
finance.yahoo.com - March 22 at 4:54 PM
Marrone Bio Innovations (MBII) Earns "Hold" Rating from Jefferies GroupMarrone Bio Innovations (MBII) Earns "Hold" Rating from Jefferies Group
www.americanbankingnews.com - March 21 at 9:32 PM

SEC Filings

Marrone Bio Innovations (NASDAQ:MBII) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Marrone Bio Innovations (NASDAQ:MBII) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Marrone Bio Innovations (NASDAQ MBII) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.